Business
AstraZeneca to run fresh COVID-19 vaccine trial amid results confusion – The Australian Financial Review
AstraZeneca and its CEO are facing scrutiny as the drugmaker responds to growing confusion over the vaccine.
AstraZeneca and its partner, the University of Oxford, reported on Monday that a lower initial dose of the vaccine, followed by a full dose, produced a 90 per cent efficacy rate, compared with 62 per cent for two full doses.
A day after the data were unveiled the head of the US vaccine program known as Operation Warp Speed said that the regimen showing the higher level of effectiveness was tested in a younger population. He also said that the half-dose was given to some people because of an error…
-
General23 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Noosa News23 hours agoHeartbreaking CCTV shows father and son moments before fatal crash in Regents Park, Queensland
-
General22 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Noosa News22 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan